# Intranasal TXA for Anterior Epistaxis in the Emergency Department

> **NCT04054687** · PHASE2 · SUSPENDED · sponsor: **Mercy Health Ohio** · enrollment: 86 (estimated)

## Conditions studied

- Epistaxis

## Interventions

- **DRUG:** Tranexamic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04054687
- **Lead sponsor:** Mercy Health Ohio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-11-07
- **Primary completion:** 2021-04
- **Final completion:** 2021-05
- **Target enrollment:** 86 (ESTIMATED)
- **Why stopped:** Due to coronavirus pandemic
- **Last updated:** 2020-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04054687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04054687, "Intranasal TXA for Anterior Epistaxis in the Emergency Department". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04054687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*